Method for Treating Obesity
OwnerKishore M. Gadde, K. Ranga R. Krishnaninventors
Life of this patent
Estimating the term…
Abstract
The present invention relates generally to methods of treating obesity and minimizing metabolic risk factors associated therewith using, for example, zonisamide or other weight loss-promoting anti-convulsant either alone or in combination with bupropion or metabolites thereof or other compound that enhances the activity of norepinephrine and/or dopamine via uptake inhibition or other mechanism.
Claims17
A method of treating obesity in a mammal comprising administering to a mammal in need of such treatment a composition according to claim 13.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method of reducing the risk of hypertension, diabetes or dyslipidaemia in a mammal comprising administering to a mammal in need of such reduction a composition according to claim 13.
(canceled)
(canceled)
A composition comprising at least one weight loss-promoting anticonvulsant and at least one compound that enhances the activity of norepinephrine and/or dopamine selected from the group consisting of bupropion, atomoxetine, and reboxetine.
Dependencies are inferred from the claim text.